ReP USP - Resultado da busca

Artigo de periodico
Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells (2023)
Los, Bruna ; Ferreira, Glaucio Monteiro ; Borges, Jéssica Bassani ; Kronenberger, Thales ; Oliveira, Victor Fernandes de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad; Mori, Augusto Akira ; Barbosa, Thais Kristini Almendros; Freitas, Renata Caroline Costa de ; Jannes, Cinthia Elim ; Pereira, Alexandre da Costa; Bastos, Gisele Medeiros ; Poso, Antti ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Gene. Unidades: FM, FCF
Assuntos: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells. Gene, v. 851, p. 1-14 art. 146979, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.146979. Acesso em: 30 ago. 2024.
APA
Los, B., Ferreira, G. M., Borges, J. B., Kronenberger, T., Oliveira, V. F. de, Hernandez, C. D., et al. (2023). Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells. Gene, 851, 1-14 art. 146979. doi:10.1016/j.gene.2022.146979
NLM
Los B, Ferreira GM, Borges JB, Kronenberger T, Oliveira VF de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Mori AA, Barbosa TKA, Freitas RCC de, Jannes CE, Pereira A da C, Bastos GM, Poso A, Hirata RDC, Hirata MH. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells [Internet]. Gene. 2023 ; 851 1-14 art. 146979.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.gene.2022.146979
Vancouver
Los B, Ferreira GM, Borges JB, Kronenberger T, Oliveira VF de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Mori AA, Barbosa TKA, Freitas RCC de, Jannes CE, Pereira A da C, Bastos GM, Poso A, Hirata RDC, Hirata MH. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells [Internet]. Gene. 2023 ; 851 1-14 art. 146979.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.gene.2022.146979
Artigo de periodico
In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia (2023)
Araújo, Jéssica Nayara Góes de ; Oliveira, Victor Fernandes de ; Borges, Jéssica Bassani ; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Jannes, Cinthia Elim; Pereira, Alexandre da Costa ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Fonte: Gene. Unidades: FM, FCF
Assuntos: HIPERCOLESTEROLEMIA, GENOMAS, BIOINFORMÁTICA, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Jéssica Nayara Góes de et al. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia. Gene, v. 849, p. 1-7 art. 146908, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.146908. Acesso em: 30 ago. 2024.
APA
Araújo, J. N. G. de, Oliveira, V. F. de, Borges, J. B., Hernandez, C. D., Marçal, E. da S. R., Freitas, R. C. C. de, et al. (2023). In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia. Gene, 849, 1-7 art. 146908. doi:10.1016/j.gene.2022.146908
NLM
Araújo JNG de, Oliveira VF de, Borges JB, Hernandez CD, Marçal E da SR, Freitas RCC de, Bastos GM, Gonçalves RM, Faludi AA, Jannes CE, Pereira A da C, Hirata RDC, Hirata MH, Luchessi AD, Silbiger VN. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia [Internet]. Gene. 2023 ; 849 1-7 art. 146908.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.gene.2022.146908
Vancouver
Araújo JNG de, Oliveira VF de, Borges JB, Hernandez CD, Marçal E da SR, Freitas RCC de, Bastos GM, Gonçalves RM, Faludi AA, Jannes CE, Pereira A da C, Hirata RDC, Hirata MH, Luchessi AD, Silbiger VN. In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia [Internet]. Gene. 2023 ; 849 1-7 art. 146908.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.gene.2022.146908
Artigo de periodico
Identification of pathogenic variants in the Brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing (2023)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Dagli-Hernandez, Carolina; Ferreira, Glaucio Monteiro ; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Los, Bruna ; Malaquias, Vanessa Barbosa ; Bortolin, Raul Hernandes ; Freitas, Renata Caroline Costa de ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Jannes, Cinthia Elim ; Pereira, Alexandre da Costa ; Wang, Jaqueline Yu Ting; Naslavsky, Michel ; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo
Fonte: Gene. Unidades: FCF, FM, IB, BIOINFORMÁTICA
Assuntos: HIPERCOLESTEROLEMIA, GENOMAS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Identification of pathogenic variants in the Brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing. Gene, v. 875, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2023.147501. Acesso em: 30 ago. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Dagli-Hernandez, C., Ferreira, G. M., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2023). Identification of pathogenic variants in the Brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing. Gene, 875. doi:10.1016/j.gene.2023.147501
NLM
Borges JB, Oliveira VF de, Dagli-Hernandez C, Ferreira GM, Barbosa TKAA, Marçal E da SR, Los B, Malaquias VB, Bortolin RH, Freitas RCC de, Mori AA, Hirata TDC, Nakaya HTI, Jannes CE, Pereira A da C, Wang JYT, Naslavsky M, Fajardo CM, Hirata RDC. Identification of pathogenic variants in the Brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing [Internet]. Gene. 2023 ; 875[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.gene.2023.147501
Vancouver
Borges JB, Oliveira VF de, Dagli-Hernandez C, Ferreira GM, Barbosa TKAA, Marçal E da SR, Los B, Malaquias VB, Bortolin RH, Freitas RCC de, Mori AA, Hirata TDC, Nakaya HTI, Jannes CE, Pereira A da C, Wang JYT, Naslavsky M, Fajardo CM, Hirata RDC. Identification of pathogenic variants in the Brazilian cohort with familial hypercholesterolemia using exon-targeted gene sequencing [Internet]. Gene. 2023 ; 875[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.gene.2023.147501
Artigo de periodico
Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia (2022)
Hernandez, Carolina Dagli ; Borges, Jéssica Bassani ; Marçal, Elisangela da Silva Rodrigues; Freitas, Renata Caroline Costa de ; Mori, Augusto Akira ; Gonçalves, Rodrigo Marques; Faludi, André Arpad ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Bastos, Gisele Medeiros ; Zhou, Yitian ; Lauschke, Volker Martin ; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: HIPERCOLESTEROLEMIA, ESTATINAS, VARIAÇÃO GENÉTICA, FARMACOGENÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, v. 14, p. 1-20 art. 944, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050944. Acesso em: 30 ago. 2024.
APA
Hernandez, C. D., Borges, J. B., Marçal, E. da S. R., Freitas, R. C. C. de, Mori, A. A., Gonçalves, R. M., et al. (2022). Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia. Pharmaceutics, 14, 1-20 art. 944. doi:10.3390/pharmaceutics14050944
NLM
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 ago. 30 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Vancouver
Hernandez CD, Borges JB, Marçal E da SR, Freitas RCC de, Mori AA, Gonçalves RM, Faludi AA, Oliveira VF de, Ferreira GM, Bastos GM, Zhou Y, Lauschke VM, Cerda A, Hirata MH, Hirata RDC. Genetic variant ABCC1 rs45511401 is Associated with increased response to statins in patients with familial hypercholesterolemia [Internet]. Pharmaceutics. 2022 ; 14 1-20 art. 944.[citado 2024 ago. 30 ] Available from: https://doi.org/10.3390/pharmaceutics14050944
Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: IDPC, ICB, FCF
Assuntos: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 30 ago. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases (2021)
Freitas, Renata Caroline Costa de ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Aikawa, Elena
Fonte: Biomolecules. Unidade: FCF
Assuntos: BIOMARCADORES, PROTEÍNAS, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, v. 11, p. 1-21 art. 388, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11030388. Acesso em: 30 ago. 2024.
APA
Freitas, R. C. C. de, Hirata, R. D. C., Hirata, M. H., & Aikawa, E. (2021). Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, 11, 1-21 art. 388. doi:10.3390/biom11030388
NLM
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 ago. 30 ] Available from: https://doi.org/10.3390/biom11030388
Vancouver
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 ago. 30 ] Available from: https://doi.org/10.3390/biom11030388
Artigo de periodico
Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Carolina Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M. ; Faludi, André A. ; Bastos, Gisele M. ; Jannes, Cinthia E. ; Pereira, Alexandre C. ; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidades: ICB, FCF
Assuntos: FARMACOLOGIA, HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, MICRORNAS, ENVELHECIMENTO, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 30 ago. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Assuntos: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 30 ago. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome (2021)
Braga, Aécio Assunção ; Bortolin, Raul Hernandes ; Saldarriaga, Magda Elizabeth Graciano ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, Hui Tzu Lin ; Borges, Jessica B; França, Joao Italo Dias ; Masi, Laureane Nunes ; Curi, Rui ; Curi, Tania Cristina Phiton ; Sampaio, Marcelo Ferraz; Castro, Lara R; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Epigenomics. Unidade: FCF
Assuntos: ADIPOSIDADE, SÍNDROME X METABÓLICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Aécio Assunção et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, v. 13, n. 6 p. 423–436, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0247. Acesso em: 30 ago. 2024.
APA
Braga, A. A., Bortolin, R. H., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2021). High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, 13( 6 p. 423–436). doi:10.2217/epi-2020-0247
NLM
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0247
Vancouver
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0247
Artigo de periodico
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study (2020)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Genvigir, Fabiana Dalla Vecchia ; Bonezi, Vivian; Hirata, Thiago Dominguez Crespo ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Epigenomics. Unidade: FCF
Assuntos: TRANSPLANTE DE RIM, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, v. 12, n. 22, p. 2019-2034, 2020Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0160. Acesso em: 30 ago. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Genvigir, F. D. V., Bonezi, V., Hirata, T. D. C., Felipe, C. R., et al. (2020). Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, 12( 22), 2019-2034. doi:10.2217/epi-2020-0160
NLM
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0160
Vancouver
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 ago. 30 ] Available from: https://doi.org/10.2217/epi-2020-0160
Trabalho de evento-resumo periodico
Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients (2019)
Bortolin, Raul Hernandes ; Freitas, Renata Caroline Costa de ; Genvigir, Fabiana Dalla Vecchia; Bonezi, Vivian; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Congress of São Paulo. Unidade: FCF
Assuntos: EXPRESSÃO GÊNICA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLIN, Raul Hernandes et al. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 30 ago. 2024. , 2019
APA
Bortolin, R. H., Freitas, R. C. C. de, Genvigir, F. D. V., Bonezi, V., Felipe, C. R., Silva Junior, H. T., et al. (2019). Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 ago. 30 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 ago. 30 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf

Unidades USP

ReP

Filtros

Unidades USP

Autores

Autores USP

Assuntos

Título da fonte

Grupo de pesquisa

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos